The report, in context
What this development means—and what it does not.
alloClae is a ready-to-use human adipose-tissue allograft intended for localized subcutaneous cushioning and support where fat naturally exists. It avoids a fat-harvest procedure, but it is not a synthetic facial filler, does not contain living cells, and carries tissue-product risks that deserve a careful candidacy and consent discussion.
Related Dagan MD pathways
Continue with the relevant clinical context.
Inclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.